Series C - Axcella
Investment Firm
Overview
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Announced Date
May 28, 2015
Funding Type
Series C
Highlights
N/A
Location
N/A
Social
N/A
Investor Lead
Flagship Pioneering
Flagship Pioneering is a debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.
Fidelity
Fidelity is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and secondary_market and seed firm.
Participant Investors
3
| Investor Name |
|---|
 Rajiv Kaul |
Round Details and Background
Axcella raised $39000000 on 2015-05-28 in Series C
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Company Funding History
6
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Feb 23, 2016 | 1 | - | 42.5M | |
| May 28, 2015 | 3 | - | 39.0M | |
| Dec 11, 2013 | 2 | - | undefined | |
| Oct 22, 2013 | 1 | - | 10.8M |
Recent Activity
There is no recent news or activity for this profile.